This site is intended for healthcare professionals only

Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. We were founded in 1876 by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission.

• Visit website →

Click here for Trulicity® (dulaglutide) Prescribing Information and Adverse Event Reporting
Adverse events and products complaints should be reported. Reporting forms and information can be found at UK: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store, or Ireland: www.hpra.ie. Adverse events and products complaints should also be reported to Lilly: please call Lilly UK on 01256 315 000, or Lilly Ireland on 01 664 0446.

Managing cardiovascular risk in adults with type 2 diabetes and the multifactorial role of Trulicity (dulaglutide)?

Dr Yassir Javaid

Trulicity Resources

Trulicity: A practical guide for Healthcare Professionals

For HCPs in Ireland and Northern Ireland only.

A GLP-1 Receptor Agonist designed with the patient in mind

For HCPs in Ireland and Northern Ireland only.

Trulicity: A practical guide for Healthcare Professionals

For HCPs in Great Britain only.

A GLP-1 Receptor Agonist designed with the patient in mind

For HCPs in Great Britain only.

Resources for online viewing only.

Trulicity is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise

  • as monotherapy when metformin is considered inappropriate due to intolerance or contraindications.
  • in addition to other medicinal products for the treatment of diabetes mellitus

This content is for UK & ROI Healthcare Professionals only. This resource page and the materials included have been organised and supported by Lilly.

PP-LD-IE-1515 | February 2022

;
Free for all UK & Ireland healthcare professionals

Sign up to all DiabetesontheNet journals

 

By clicking ‘Subscribe’, you are agreeing that DiabetesontheNet.com are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our Privacy Policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.